No black box warning on record for Inlexzo
As of the latest FDA labeling reviewed, Inlexzo (GEMCITABINE INTRAVESICAL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Inlexzo medicine page for the complete safety profile.